Company page
Dianthus Therapeutics, Inc.
Dianthus Therapeutics, Inc. is a public company traded under the ticker DNTH in the American market. The company has a market capitalization of approximately $5.68 billion. Dianthus focuses on developing innovative therapies in the biotechnology sector.
- Ticker
- DNTH:NASDAQ
- Asset type
- Stock
- Market cap
- $5.92B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD